WHO 2024 data call for antifungals in the preclinical development pipeline

  18 May 2024

The World Health Organization (WHO) is reviewing its antifungal clinical and preclinical pipeline to evaluate global preparedness against fungal infections and antifungal resistance. The WHO’s fungal priority pathogens list (FPPL) identifies 19 fungi as the greatest threat to public health. The WHO is inviting developers to share information on their preclinical research projects to strengthen the global response to invasive fungal diseases. The 2024 data call aims to collect data on antifungal agents in the preclinical development pipeline, which includes lead optimization, preclinical candidates, and formal CTA/IND enabling studies before human testing. The data will be available for stakeholders, including existing and future funders of R&D, through the WHO Global Health R&D Observatory.

Further reading: WHO
Author(s): WHO
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed